data_1emn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1emn _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A 2124 ' ' SER . . . . . 0.693 ' O ' ' CB ' ' A' 2125 ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.565 -0.532 . . . . 8.5600000000000005 109.565 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2125 ' ' ALA . . . . . 0.693 ' CB ' ' O ' ' A' 2124 ' ' SER . . . 95.97 38.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.618 -0.676 . . . . 5.5599999999999996 109.704 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2126 ' ' VAL . . . . . 0.46 ' O ' ' CG1' ' A' 2126 ' ' VAL . 0.9 OUTLIER -51.61 107.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 4.4699999999999998 109.076 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.517 ' O ' ' C ' ' A' 2128 ' ' MET . 42.6 t0 -43.92 106.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 2.6499999999999999 109.259 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2128 ' ' MET . . . . . 0.517 ' C ' ' O ' ' A' 2127 ' ' ASP . 6.5 mtt -35.17 121.94 0.57 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 2.8700000000000001 109.711 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.66 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 10.1 t0 -57.81 -49.43 76.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.705 -0.85 . . . . 1.3799999999999999 108.705 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.587 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.6 mt-10 79.52 -41.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.649 -0.657 . . . . 1.46 110.162 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.546 ' HA ' HG13 ' A' 2136 ' ' VAL . 0.7 OUTLIER -90.48 -29.22 18.06 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.041 -1.037 . . . . 1.5700000000000001 109.56 -179.959 91.128 152.386 18.986 103.837 2.018 103.961 163.016 40.516 3 3 . 1 . 001 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.514 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -76.72 -2.32 32.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 3.3500000000000001 109.47 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.534 ' HB2' HG22 ' A' 2136 ' ' VAL . 5.9 mt-10 -70.07 145.54 94.01 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.246 -0.909 . . . . 1.8999999999999999 109.339 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.512 ' O ' ' HD2' ' A' 2138 ' ' LYS . 2.9 Cg_endo -66.23 -1.76 5.94 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.706 2.271 . . . . 1.78 111.096 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -125.23 10.93 8.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.885 -1.134 . . . . 2.6499999999999999 110.062 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.546 HG13 ' HA ' ' A' 2131 ' ' CYS . 67.3 t -114.4 -105.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.99 -1.069 . . . . 1.6200000000000001 110.131 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.774 ' O ' ' HB2' ' A' 2138 ' ' LYS . 0.9 OUTLIER -63.31 -87.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 1.8999999999999999 110.319 -179.221 -101.195 25.5 -141.763 104.611 2.02 103.705 -51.803 -84.737 3 3 . 1 . 001 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.774 ' HB2' ' O ' ' A' 2137 ' ' CYS . 2.4 mtpt 76.43 93.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.541 -0.724 . . . . 2.3500000000000001 109.569 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.587 ' HB2' ' O ' ' A' 2138 ' ' LYS . 8.5 m170 72.49 54.25 0.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.485 -0.759 . . . . 2.9100000000000001 110.154 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -162.34 164.93 35.83 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.92 -1.272 . . . . 1.0600000000000001 109.92 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -92.74 112.49 24.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -1.119 . . . . 3.27 108.77 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.542 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 1.8 p -111.46 174.84 5.68 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.168 -0.958 . . . . 1.4299999999999999 110.38 -179.119 40.516 163.016 18.986 103.961 2.018 103.837 152.386 91.128 2 2 . 1 . 001 nuclear orig full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.16 106.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.491 -0.929 . . . . 1.8700000000000001 108.491 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.66 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 6.3 t-20 -60.95 117.03 4.95 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.339 -0.851 . . . . 1.8500000000000001 110.309 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.448 ' OG1' ' C ' ' A' 2148 ' ' SER . 76.6 p -104.74 -178.13 3.57 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.928 -0.767 . . . . 1.6799999999999999 108.928 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -80.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 2.48 109.517 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -118.43 49.33 0.87 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.543 -1.423 . . . . 1.8600000000000001 109.543 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.494 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -169.39 -161.4 0.3 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 1.9299999999999999 109.293 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.587 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 36.0 p90 -168.17 -175.77 2.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.895 . . . . 2.4100000000000001 109.858 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' 2149 ' ' TYR . 76.1 mtt180 -152.87 113.47 4.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.556 -0.715 . . . . 3.6600000000000001 109.139 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 7.3 m -85.89 86.13 7.36 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.364 -0.835 . . . . 1.7 109.823 -179.767 -84.737 -51.803 -141.763 103.705 2.02 104.611 25.5 -101.195 1 1 . 1 . 001 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.82 105.88 17.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 2.48 109.097 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.56 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -71.89 153.69 92.92 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.269 -0.894 . . . . 1.23 109.669 -179.739 -118.97 81.498 -169.419 104.52 2.019 104.025 -92.94 -123.708 3 3 . 1 . 001 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -63.5 -168.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.721 2.281 . . . . 1.1899999999999999 110.966 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 5.3 t80 -90.29 101.46 14.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.228 -1.027 . . . . 3.0499999999999998 108.228 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.92 -12.67 5.58 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.118 -1.993 . . . . 1.1399999999999999 108.118 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.56 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 8.4 m-85 -109.13 -170.98 1.75 Allowed 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.579 -0.954 . . . . 2.3900000000000001 110.022 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.672 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -156.82 -165.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.563 -0.711 . . . . 1.53 109.311 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.441 HD11 ' SG ' ' A' 2164 ' ' CYS . 26.4 tp -138.76 124.12 19.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 1.5 109.485 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -100.36 56.65 0.92 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 1.47 109.44 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2161 ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 85.93 -8.59 72.45 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.417 -1.473 . . . . 1.1799999999999999 109.417 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' 2161 ' ' GLY . 1.3 m-20 166.79 -53.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -1.124 . . . . 2.6400000000000001 109.478 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -65.41 121.84 15.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 1.8600000000000001 109.462 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.556 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -97.27 137.13 36.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.96999999999999997 109.52 -179.907 -123.708 -92.94 -169.419 104.025 2.019 104.52 81.498 -118.97 3 3 . 1 . 001 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.51 ' C ' ' CD2' ' A' 2157 ' ' TYR . 1.1 m -156.87 -165.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 1.45 109.46 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 2.4 t70 -90.09 155.69 18.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.96 -1.088 . . . . 1.3300000000000001 109.862 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.672 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 15.0 t -100.41 -177.33 3.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 1.26 109.416 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' 2171 ' ' SER . 43.2 t0 -99.97 95.84 7.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.70999999999999996 109.095 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.733 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -68.81 -32.59 72.41 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.287 -0.883 . . . . 1.3 109.373 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.602 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.5 OUTLIER -65.79 -9.8 31.75 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.253 -0.904 . . . . 0.85999999999999999 109.104 179.253 154.174 56.673 27.174 105.157 2.021 104.631 88.015 55.717 3 3 . 1 . 001 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -73.06 -9.97 59.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 1.73 109.641 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 23.5 t -90.27 -73.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 1.8799999999999999 109.452 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.493 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -165.43 139.12 5.62 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.559 -1.417 . . . . 1.8100000000000001 109.559 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.777 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 19.9 p-10 -38.87 99.83 0.2 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.419 -1.047 . . . . 2.3900000000000001 109.875 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.621 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 2.0 Cg_endo -63.03 -23.85 73.83 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.061 1.841 . . . . 0.77000000000000002 109.975 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.618 ' O ' ' CB ' ' A' 2204 ' ' CYS . 0.0 OUTLIER -56.83 -13.25 2.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.98999999999999999 109.393 -179.988 -116.876 56.267 55.739 104.156 2.019 103.902 92.057 79.46 3 3 . 1 . 001 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 98.3 -33.99 5.59 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.521 -1.432 . . . . 1.1499999999999999 109.521 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2178 ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.8 OUTLIER -154.31 -36.46 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 2.52 110.25 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.651 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -58.19 -121.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.988 -1.245 . . . . 0.93999999999999995 109.988 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.51 154.65 45.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -1.203 . . . . 1.55 109.473 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.777 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 22.2 p -89.74 160.22 16.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.186 -0.947 . . . . 0.62 110.301 -179.699 55.717 88.015 27.174 104.631 2.021 105.157 56.673 154.174 2 2 . 1 . 001 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.688 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 6.5 tptt -143.68 157.43 44.41 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.392 -1.336 . . . . 2.48 107.392 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.464 ' N ' ' HG3' ' A' 2182 ' ' LYS . 58.6 t30 -97.36 137.45 36.33 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.613 -1.305 . . . . 0.68999999999999995 109.36 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.52 ' CG1' ' CA ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.43 -170.85 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.415 -0.803 . . . . 1.3700000000000001 109.238 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.553 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.3 mp -103.7 140.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 1.72 109.945 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2186 ' ' GLY . . . . . 0.482 ' N ' HG21 ' A' 2185 ' ' ILE . . . 68.58 12.93 64.91 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.794 -1.322 . . . . 1.05 109.794 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.535 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 162.76 -120.62 0.96 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.502 -1.439 . . . . 0.79000000000000004 109.502 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.733 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 2.3 p90 -169.89 178.59 3.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -1.197 . . . . 2.2400000000000002 109.453 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.688 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.1 OUTLIER -123.88 151.68 43.21 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.629 -0.878 . . . . 1.5600000000000001 108.629 178.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 9.2 p -149.15 143.01 25.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.878 -1.139 . . . . 0.81999999999999995 109.629 -179.725 79.46 92.057 55.739 103.902 2.019 104.156 56.267 -116.876 1 1 . 1 . 001 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' 2192 ' ' CYS . 95.3 m -118.14 90.38 3.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 1.48 109.396 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.651 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 0.8 OUTLIER -49.16 -176.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.98999999999999999 109.558 179.99 -102.937 138.909 -143.641 103.978 2.02 103.572 148.886 -164.503 3 3 . 1 . 001 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.627 ' O ' ' C ' ' A' 2194 ' ' GLU . 25.8 tt0 -60.54 106.07 0.51 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.478 -0.934 . . . . 2.52 108.478 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.627 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.1 mt-10 -19.85 128.2 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.712 -0.617 . . . . 2.73 110.749 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.92 4.28 9.54 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.247 -1.541 . . . . 1.5800000000000001 109.247 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.756 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.4 p90 -119.79 -164.45 1.07 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.306 -1.114 . . . . 2.3700000000000001 110.248 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.563 ' N ' ' CG ' ' A' 2196 ' ' PHE . 5.7 mt-10 -141.35 95.29 7.37 Favored Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 121.523 -0.735 . . . . 2.5699999999999998 109.619 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.756 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.8 Cg_endo -66.78 -160.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.303 2.002 . . . . 0.94999999999999996 110.801 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -142.5 -171.69 13.37 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.067 -1.613 . . . . 0.83999999999999997 109.067 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.45 -80.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.293 1.995 . . . . 1.04 110.543 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.535 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -139.32 49.82 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 2.7400000000000002 109.962 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -118.74 -76.02 0.58 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.105 -0.997 . . . . 2.1800000000000002 109.794 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 13.3 t -174.07 -166.86 0.31 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.307 -0.871 . . . . 1.25 109.607 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.618 ' CB ' ' O ' ' A' 2176 ' ' CYS . 10.9 t -82.11 151.32 27.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.385 -0.822 . . . . 1.52 109.749 -179.877 -164.503 148.886 -143.641 103.572 2.02 103.978 138.909 -102.937 2 2 . 1 . 001 nuclear orig full ' A' A 2205 ' ' GLU . . . . . 0.439 ' OXT' ' HG3' ' A' 2205 ' ' GLU . 18.1 pt-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.998 -1.001 . . . . 2.4100000000000001 109.413 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 2124 ' ' SER . . . . . 0.767 ' O ' ' HB3' ' A' 2125 ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.565 -0.532 . . . . 8.26 109.565 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2125 ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' 2124 ' ' SER . . . 95.97 38.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.618 -0.676 . . . . 5.43 109.704 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2126 ' ' VAL . . . . . 0.675 ' O ' HG12 ' A' 2126 ' ' VAL . 0.9 OUTLIER -51.61 107.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 4.14 109.076 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.517 ' O ' ' C ' ' A' 2128 ' ' MET . 42.6 t0 -43.92 106.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 2.64 109.259 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2128 ' ' MET . . . . . 0.517 ' C ' ' O ' ' A' 2127 ' ' ASP . 6.5 mtt -35.17 121.94 0.57 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 2.47 109.711 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.663 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 10.1 t0 -57.81 -49.43 76.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.705 -0.85 . . . . 1.38 108.705 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.78 ' O ' HG21 ' A' 2136 ' ' VAL . 1.6 mt-10 79.52 -41.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.649 -0.657 . . . . 1.46 110.162 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' 2137 ' ' CYS . 0.7 OUTLIER -90.48 -29.22 18.06 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.041 -1.037 . . . . 1.56 109.56 -179.959 91.128 152.386 18.986 103.837 2.018 103.961 163.016 40.516 3 3 . 1 . 001 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.516 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -76.72 -2.32 32.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 3.0 109.47 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' 2136 ' ' VAL . 5.9 mt-10 -70.07 145.54 94.01 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.246 -0.909 . . . . 1.9 109.339 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.512 ' O ' ' HD2' ' A' 2138 ' ' LYS . 2.9 Cg_endo -66.23 -1.76 5.94 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.706 2.271 . . . . 1.63 111.096 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -125.23 10.93 8.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.885 -1.134 . . . . 2.65 110.062 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.78 HG21 ' O ' ' A' 2130 ' ' GLU . 67.3 t -114.4 -105.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.99 -1.069 . . . . 1.59 110.131 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.767 ' O ' ' HB2' ' A' 2138 ' ' LYS . 0.9 OUTLIER -63.31 -87.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 1.9 110.319 -179.221 -101.195 25.5 -141.763 104.611 2.02 103.705 -51.803 -84.737 3 3 . 1 . 001 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.767 ' HB2' ' O ' ' A' 2137 ' ' CYS . 2.4 mtpt 76.43 93.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.541 -0.724 . . . . 1.86 109.569 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.578 ' HB2' ' O ' ' A' 2138 ' ' LYS . 0.3 OUTLIER 72.49 54.25 0.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.485 -0.759 . . . . 2.26 110.154 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -162.34 164.93 35.83 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.92 -1.272 . . . . 0.93 109.92 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -92.74 112.49 24.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -1.119 . . . . 2.72 108.77 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.728 ' C ' HD12 ' A' 2143 ' ' ILE . 1.8 p -111.46 174.84 5.68 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.168 -0.958 . . . . 1.43 110.38 -179.119 40.516 163.016 18.986 103.961 2.018 103.837 152.386 91.128 2 2 . 1 . 001 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.728 HD12 ' C ' ' A' 2142 ' ' CYS . 4.2 mp -136.16 106.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.491 -0.929 . . . . 1.35 108.491 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.663 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 6.3 t-20 -60.95 117.03 4.95 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.339 -0.851 . . . . 1.38 110.309 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.448 ' OG1' ' C ' ' A' 2148 ' ' SER . 76.6 p -104.74 -178.13 3.57 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.928 -0.767 . . . . 1.14 108.928 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -80.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 2.48 109.517 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -118.43 49.33 0.87 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.543 -1.423 . . . . 1.6 109.543 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.494 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -169.39 -161.4 0.3 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 1.68 109.293 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 36.0 p90 -168.17 -175.77 2.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.895 . . . . 1.55 109.858 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' 2149 ' ' TYR . 76.1 mtt180 -152.87 113.47 4.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.556 -0.715 . . . . 3.04 109.139 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 7.3 m -85.89 86.13 7.36 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.364 -0.835 . . . . 1.7 109.823 -179.767 -84.737 -51.803 -141.763 103.705 2.02 104.611 25.5 -101.195 1 1 . 1 . 001 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.82 105.88 17.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 2.48 109.097 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -71.89 153.69 92.92 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.269 -0.894 . . . . 1.13 109.669 -179.739 -118.97 81.498 -169.419 104.52 2.019 104.025 -92.94 -123.708 3 3 . 1 . 001 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.493 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -63.5 -168.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.721 2.281 . . . . 1.16 110.966 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 5.3 t80 -90.29 101.46 14.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.228 -1.027 . . . . 2.29 108.228 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.92 -12.67 5.58 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.118 -1.993 . . . . 1.13 108.118 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.592 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 8.4 m-85 -109.13 -170.98 1.75 Allowed 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.579 -0.954 . . . . 1.58 110.022 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.753 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -156.82 -165.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.563 -0.711 . . . . 1.08 109.311 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.596 HD11 ' O ' ' A' 2162 ' ' ASN . 26.4 tp -138.76 124.12 19.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 1.0 109.485 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -100.36 56.65 0.92 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 1.13 109.44 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2161 ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 85.93 -8.59 72.45 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.417 -1.473 . . . . 1.03 109.417 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.596 ' O ' HD11 ' A' 2159 ' ' LEU . 1.3 m-20 166.79 -53.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -1.124 . . . . 2.13 109.478 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -65.41 121.84 15.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 1.86 109.462 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.572 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -97.27 137.13 36.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.97 109.52 -179.907 -123.708 -92.94 -169.419 104.025 2.019 104.52 81.498 -118.97 3 3 . 1 . 001 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.653 HG23 HD11 ' A' 2158 ' ' ILE . 1.1 m -156.87 -165.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.92 109.46 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 2.4 t70 -90.09 155.69 18.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.96 -1.088 . . . . 1.33 109.862 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.756 HG23 ' OE1' ' A' 2169 ' ' GLU . 15.0 t -100.41 -177.33 3.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 0.75 109.416 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' 2171 ' ' SER . 43.2 t0 -99.97 95.84 7.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.66 109.095 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.768 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -68.81 -32.59 72.41 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.287 -0.883 . . . . 1.3 109.373 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.635 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.5 OUTLIER -65.79 -9.8 31.75 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.253 -0.904 . . . . 0.86 109.104 179.253 154.174 56.673 27.174 105.157 2.021 104.631 88.015 55.717 3 3 . 1 . 001 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -73.06 -9.97 59.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 1.36 109.641 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 23.5 t -90.27 -73.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 1.49 109.452 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -165.43 139.12 5.62 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.559 -1.417 . . . . 1.81 109.559 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.791 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 19.9 p-10 -38.87 99.83 0.2 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.419 -1.047 . . . . 2.03 109.875 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.644 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 2.0 Cg_endo -63.03 -23.85 73.83 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.061 1.841 . . . . 0.73 109.975 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.64 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -56.83 -13.25 2.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.99 109.393 -179.988 -116.876 56.267 55.739 104.156 2.019 103.902 92.057 79.46 3 3 . 1 . 001 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 98.3 -33.99 5.59 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.521 -1.432 . . . . 1.15 109.521 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2178 ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.3 OUTLIER -154.31 -36.46 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 2.06 110.25 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.667 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -58.19 -121.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.988 -1.245 . . . . 0.94 109.988 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.51 154.65 45.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -1.203 . . . . 0.91 109.473 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.791 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 22.2 p -89.74 160.22 16.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.186 -0.947 . . . . 0.55 110.301 -179.699 55.717 88.015 27.174 104.631 2.021 105.157 56.673 154.174 2 2 . 1 . 001 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.716 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 6.5 tptt -143.68 157.43 44.41 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.392 -1.336 . . . . 2.05 107.392 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 58.6 t30 -97.36 137.45 36.33 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.613 -1.305 . . . . 0.64 109.36 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.775 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.43 -170.85 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.415 -0.803 . . . . 0.74 109.238 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.645 ' N ' HG13 ' A' 2184 ' ' VAL . 3.3 mp -103.7 140.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 1.21 109.945 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2186 ' ' GLY . . . . . 0.408 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 68.58 12.93 64.91 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.794 -1.322 . . . . 0.97 109.794 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.592 ' C ' HG12 ' A' 2184 ' ' VAL . . . 162.76 -120.62 0.96 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.502 -1.439 . . . . 0.79 109.502 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.775 ' N ' HG12 ' A' 2184 ' ' VAL . 2.3 p90 -169.89 178.59 3.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -1.197 . . . . 1.35 109.453 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.716 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.1 OUTLIER -123.88 151.68 43.21 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.629 -0.878 . . . . 1.56 108.629 178.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 9.2 p -149.15 143.01 25.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.878 -1.139 . . . . 0.82 109.629 -179.725 79.46 92.057 55.739 103.902 2.019 104.156 56.267 -116.876 1 1 . 1 . 001 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' 2192 ' ' CYS . 95.3 m -118.14 90.38 3.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.94 109.396 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.667 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 0.8 OUTLIER -49.16 -176.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.99 109.558 179.99 -102.937 138.909 -143.641 103.978 2.02 103.572 148.886 -164.503 3 3 . 1 . 001 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.627 ' O ' ' C ' ' A' 2194 ' ' GLU . 25.8 tt0 -60.54 106.07 0.51 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.478 -0.934 . . . . 2.52 108.478 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.627 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.1 mt-10 -19.85 128.2 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.712 -0.617 . . . . 2.73 110.749 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.92 4.28 9.54 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.247 -1.541 . . . . 1.49 109.247 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.756 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.4 p90 -119.79 -164.45 1.07 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.306 -1.114 . . . . 1.52 110.248 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.563 ' N ' ' CG ' ' A' 2196 ' ' PHE . 5.7 mt-10 -141.35 95.29 7.37 Favored Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 121.523 -0.735 . . . . 2.57 109.619 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.756 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.8 Cg_endo -66.78 -160.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.303 2.002 . . . . 0.86 110.801 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -142.5 -171.69 13.37 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.067 -1.613 . . . . 0.76 109.067 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.45 -80.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.293 1.995 . . . . 0.97 110.543 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.56 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -139.32 49.82 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 2.25 109.962 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -118.74 -76.02 0.58 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.105 -0.997 . . . . 1.66 109.794 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 13.3 t -174.07 -166.86 0.31 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.307 -0.871 . . . . 0.69 109.607 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.64 ' HB2' ' O ' ' A' 2176 ' ' CYS . 10.9 t -82.11 151.32 27.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.385 -0.822 . . . . 1.03 109.749 -179.877 -164.503 148.886 -143.641 103.572 2.02 103.978 138.909 -102.937 2 2 . 1 . 001 nuclear build full ' A' A 2205 ' ' GLU . . . . . 0.447 ' OXT' ' HG3' ' A' 2205 ' ' GLU . 18.1 pt-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.998 -1.001 . . . . 2.41 109.413 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . 0.767 ' O ' ' HB3' ' A' 2125 ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.565 -0.532 . . . . 8.26 109.565 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . 0.767 ' HB3' ' O ' ' A' 2124 ' ' SER . . . 95.97 38.86 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.618 -0.676 . . . . 5.43 109.704 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . 0.675 ' O ' HG12 ' A' 2126 ' ' VAL . 0.9 OUTLIER -51.61 107.61 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.909 . . . . 4.14 109.076 179.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.517 ' O ' ' C ' ' A' 2128 ' ' MET . 42.6 t0 -43.92 106.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 2.64 109.259 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . 0.517 ' C ' ' O ' ' A' 2127 ' ' ASP . 6.5 mtt -35.17 121.94 0.57 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.439 -0.788 . . . . 2.47 109.711 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.663 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 10.1 t0 -57.81 -49.43 76.68 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.705 -0.85 . . . . 1.38 108.705 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.78 ' O ' HG21 ' A' 2136 ' ' VAL . 1.6 mt-10 79.52 -41.87 0.25 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.649 -0.657 . . . . 1.46 110.162 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' 2137 ' ' CYS . 0.7 OUTLIER -90.48 -29.22 18.06 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.041 -1.037 . . . . 1.56 109.56 -179.959 91.128 152.386 18.986 103.837 2.018 103.961 163.016 40.516 3 3 . 1 . 001 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.516 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -76.72 -2.32 32.42 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 3.0 109.47 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' 2136 ' ' VAL . 5.9 mt-10 -70.07 145.54 94.01 Favored Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.246 -0.909 . . . . 1.9 109.339 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.512 ' O ' ' HD2' ' A' 2138 ' ' LYS . 2.9 Cg_endo -66.23 -1.76 5.94 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.706 2.271 . . . . 1.63 111.096 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -125.23 10.93 8.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.885 -1.134 . . . . 2.65 110.062 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.78 HG21 ' O ' ' A' 2130 ' ' GLU . 67.3 t -114.4 -105.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.99 -1.069 . . . . 1.59 110.131 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.767 ' O ' ' HB2' ' A' 2138 ' ' LYS . 0.9 OUTLIER -63.31 -87.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 1.9 110.319 -179.221 -101.195 25.5 -141.763 104.611 2.02 103.705 -51.803 -84.737 3 3 . 1 . 001 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.767 ' HB2' ' O ' ' A' 2137 ' ' CYS . 2.4 mtpt 76.43 93.13 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.541 -0.724 . . . . 1.86 109.569 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.578 ' HB2' ' O ' ' A' 2138 ' ' LYS . 8.5 m170 72.49 54.25 0.16 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.485 -0.759 . . . . 2.26 110.154 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -162.34 164.93 35.83 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.92 -1.272 . . . . 0.93 109.92 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -92.74 112.49 24.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -1.119 . . . . 2.72 108.77 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.728 ' C ' HD12 ' A' 2143 ' ' ILE . 1.8 p -111.46 174.84 5.68 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.168 -0.958 . . . . 1.43 110.38 -179.119 40.516 163.016 18.986 103.961 2.018 103.837 152.386 91.128 2 2 . 1 . 001 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.728 HD12 ' C ' ' A' 2142 ' ' CYS . 4.2 mp -136.16 106.14 5.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.491 -0.929 . . . . 1.35 108.491 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.663 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 6.3 t-20 -60.95 117.03 4.95 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.339 -0.851 . . . . 1.38 110.309 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.448 ' OG1' ' C ' ' A' 2148 ' ' SER . 76.6 p -104.74 -178.13 3.57 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.928 -0.767 . . . . 1.14 108.928 179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -80.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -0.904 . . . . 2.48 109.517 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -118.43 49.33 0.87 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.543 -1.423 . . . . 1.6 109.543 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.494 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -169.39 -161.4 0.3 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.29 -1.124 . . . . 1.68 109.293 179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.619 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 36.0 p90 -168.17 -175.77 2.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.895 . . . . 1.55 109.858 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.514 ' HG3' ' O ' ' A' 2149 ' ' TYR . 76.1 mtt180 -152.87 113.47 4.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.556 -0.715 . . . . 3.04 109.139 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 7.3 m -85.89 86.13 7.36 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.364 -0.835 . . . . 1.7 109.823 -179.767 -84.737 -51.803 -141.763 103.705 2.02 104.611 25.5 -101.195 1 1 . 1 . 001 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.82 105.88 17.84 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 2.48 109.097 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.592 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -71.89 153.69 92.92 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.269 -0.894 . . . . 1.13 109.669 -179.739 -118.97 81.498 -169.419 104.52 2.019 104.025 -92.94 -123.708 3 3 . 1 . 001 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.493 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -63.5 -168.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.721 2.281 . . . . 1.16 110.966 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 5.3 t80 -90.29 101.46 14.19 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.228 -1.027 . . . . 2.29 108.228 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.92 -12.67 5.58 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.118 -1.993 . . . . 1.13 108.118 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.592 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 8.4 m-85 -109.13 -170.98 1.75 Allowed 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.579 -0.954 . . . . 1.58 110.022 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.753 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -156.82 -165.45 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.563 -0.711 . . . . 1.08 109.311 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.596 HD11 ' O ' ' A' 2162 ' ' ASN . 26.4 tp -138.76 124.12 19.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.325 -0.859 . . . . 1.0 109.485 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -100.36 56.65 0.92 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.373 -0.829 . . . . 1.13 109.44 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . 0.476 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 85.93 -8.59 72.45 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.417 -1.473 . . . . 1.03 109.417 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.596 ' O ' HD11 ' A' 2159 ' ' LEU . 1.3 m-20 166.79 -53.91 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -1.124 . . . . 2.13 109.478 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 72.0 tt0 -65.41 121.84 15.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 1.86 109.462 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.572 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -97.27 137.13 36.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.274 -0.891 . . . . 0.97 109.52 -179.907 -123.708 -92.94 -169.419 104.025 2.019 104.52 81.498 -118.97 3 3 . 1 . 001 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.653 HG23 HD11 ' A' 2158 ' ' ILE . 1.1 m -156.87 -165.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.92 109.46 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 2.4 t70 -90.09 155.69 18.89 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.96 -1.088 . . . . 1.33 109.862 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.756 HG23 ' OE1' ' A' 2169 ' ' GLU . 15.0 t -100.41 -177.33 3.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.341 -0.849 . . . . 0.75 109.416 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' 2171 ' ' SER . 43.2 t0 -99.97 95.84 7.14 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.241 -0.912 . . . . 0.66 109.095 179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.768 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -68.81 -32.59 72.41 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.287 -0.883 . . . . 1.3 109.373 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.635 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.5 OUTLIER -65.79 -9.8 31.75 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.253 -0.904 . . . . 0.86 109.104 179.253 154.174 56.673 27.174 105.157 2.021 104.631 88.015 55.717 3 3 . 1 . 001 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -73.06 -9.97 59.3 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 1.36 109.641 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 23.5 t -90.27 -73.52 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.25 -0.906 . . . . 1.49 109.452 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.472 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -165.43 139.12 5.62 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.559 -1.417 . . . . 1.81 109.559 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.791 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 19.9 p-10 -38.87 99.83 0.2 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.419 -1.047 . . . . 2.03 109.875 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.644 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 2.0 Cg_endo -63.03 -23.85 73.83 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.061 1.841 . . . . 0.73 109.975 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.64 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -56.83 -13.25 2.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 0.99 109.393 -179.988 -116.876 56.267 55.739 104.156 2.019 103.902 92.057 79.46 3 3 . 1 . 001 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 98.3 -33.99 5.59 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.521 -1.432 . . . . 1.15 109.521 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.8 OUTLIER -154.31 -36.46 0.1 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 2.06 110.25 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.667 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -58.19 -121.33 0.01 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.988 -1.245 . . . . 0.94 109.988 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.51 154.65 45.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.155 -1.203 . . . . 0.91 109.473 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.791 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 22.2 p -89.74 160.22 16.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.186 -0.947 . . . . 0.55 110.301 -179.699 55.717 88.015 27.174 104.631 2.021 105.157 56.673 154.174 2 2 . 1 . 001 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.716 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 6.5 tptt -143.68 157.43 44.41 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.392 -1.336 . . . . 2.05 107.392 179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 58.6 t30 -97.36 137.45 36.33 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.613 -1.305 . . . . 0.64 109.36 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.775 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.43 -170.85 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.415 -0.803 . . . . 0.74 109.238 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.645 ' N ' HG13 ' A' 2184 ' ' VAL . 3.3 mp -103.7 140.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.135 -0.978 . . . . 1.21 109.945 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . 0.408 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 68.58 12.93 64.91 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 109.794 -1.322 . . . . 0.97 109.794 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.592 ' C ' HG12 ' A' 2184 ' ' VAL . . . 162.76 -120.62 0.96 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.502 -1.439 . . . . 0.79 109.502 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.775 ' N ' HG12 ' A' 2184 ' ' VAL . 2.3 p90 -169.89 178.59 3.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -1.197 . . . . 1.35 109.453 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.716 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.1 OUTLIER -123.88 151.68 43.21 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.629 -0.878 . . . . 1.56 108.629 178.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 9.2 p -149.15 143.01 25.7 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.878 -1.139 . . . . 0.82 109.629 -179.725 79.46 92.057 55.739 103.902 2.019 104.156 56.267 -116.876 1 1 . 1 . 001 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' 2192 ' ' CYS . 95.3 m -118.14 90.38 3.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.276 -0.89 . . . . 0.94 109.396 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.667 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 0.8 OUTLIER -49.16 -176.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.88 . . . . 0.99 109.558 179.99 -102.937 138.909 -143.641 103.978 2.02 103.572 148.886 -164.503 3 3 . 1 . 001 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.627 ' O ' ' C ' ' A' 2194 ' ' GLU . 25.8 tt0 -60.54 106.07 0.51 Allowed 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.478 -0.934 . . . . 2.52 108.478 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.627 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.1 mt-10 -19.85 128.2 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.712 -0.617 . . . . 2.73 110.749 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.92 4.28 9.54 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.247 -1.541 . . . . 1.49 109.247 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.756 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.4 p90 -119.79 -164.45 1.07 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.306 -1.114 . . . . 1.52 110.248 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.563 ' N ' ' CG ' ' A' 2196 ' ' PHE . 5.7 mt-10 -141.35 95.29 7.37 Favored Pre-proline 0 C--N 1.303 -1.424 0 O-C-N 121.523 -0.735 . . . . 2.57 109.619 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.756 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.8 Cg_endo -66.78 -160.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.303 2.002 . . . . 0.86 110.801 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -142.5 -171.69 13.37 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.067 -1.613 . . . . 0.76 109.067 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.45 -80.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.293 1.995 . . . . 0.97 110.543 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.56 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -139.32 49.82 1.81 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 2.25 109.962 -179.582 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -118.74 -76.02 0.58 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.105 -0.997 . . . . 1.66 109.794 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 13.3 t -174.07 -166.86 0.31 Allowed 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.307 -0.871 . . . . 0.69 109.607 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.64 ' HB2' ' O ' ' A' 2176 ' ' CYS . 10.9 t -82.11 151.32 27.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.385 -0.822 . . . . 1.03 109.749 -179.877 -164.503 148.886 -143.641 103.572 2.02 103.978 138.909 -102.937 2 2 . 1 . 001 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . 0.447 ' OXT' ' HG3' ' A' 2205 ' ' GLU . 18.1 pt-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.998 -1.001 . . . . 2.41 109.413 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_